Helping You Improve Lives Through Advanced Brain Therapy
As the official distributor of MagVenture TMS in Singapore, Magflux is committed to supporting clinicians with best-in-class brain stimulation tools, grounded in research, focused on results, and dedicated to patient recovery.
We bridge the gap between cutting-edge medical technology and clinical practice, ensuring that healthcare professionals have access to the most advanced neurostimulation solutions available.
Leading the future of neurostimulation technology
Expanding access to advanced neurostimulation therapy
To transform mental health outcomes across Southeast Asia by making cutting-edge brain stimulation technology accessible, trusted, and widely adopted.
We envision a future where advanced neurostimulation treatments are readily available to all patients who can benefit from them, supported by comprehensive clinical expertise and ongoing innovation.
Our core values guide everything we do, from product selection to customer service, ensuring we deliver exceptional value to healthcare providers and their patients.
We maintain the highest standards in product quality, service delivery, and clinical support.
We build lasting relationships with healthcare providers, supporting their clinical success and patient outcomes.
We continuously seek and deliver the most advanced neurostimulation technologies to advance patient care.
Our experienced leadership team brings together expertise in medical technology, clinical practice, and business development to drive our mission forward.
Magflux is led by our founder with over 15 years of experience in medtech, forged through leadership roles at top multinational distributors. Since entering the industry in 2008, he has cultivated deep expertise in medical device strategy, clinical adoption, and regulatory pathways across Southeast Asia.
A passionate advocate for non-invasive brain technologies, he recognized early the growing need for safe, effective alternatives—not only for mental health conditions such as depression and anxiety, but also for a broader spectrum of neurological disorders.
He brings a leadership approach shaped by discipline, domain expertise, and strategic insight. With a strong track record in navigating clinical and commercial environments, he guides Magflux with clarity of purpose—focused on enabling the adoption of advanced neurotechnologies that meet real clinical needs.